Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer
暂无分享,去创建一个
R. Arai | P. Hoff | R. Barroso-Sousa | F. Andrade | M. Mano | M. Ricci | A.I.C. Leal | J. R. Piato | E. Longo | D. Gagliato | V. Petry | J. Piato